Success Metrics

Clinical Success Rate
91.7%

Based on 22 completed trials

Completion Rate
92%(22/24)
Active Trials
8(22%)
Results Posted
9%(2 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_1
1
3%
Ph early_phase_1
1
3%
Ph phase_2
3
8%
Ph phase_3
3
8%
Ph not_applicable
20
54%
Ph phase_4
7
19%

Phase Distribution

2

Early Stage

3

Mid Stage

10

Late Stage

Phase Distribution35 total trials
Early Phase 1First-in-human
1(2.9%)
Phase 1Safety & dosage
1(2.9%)
Phase 2Efficacy & side effects
3(8.6%)
Phase 3Large-scale testing
3(8.6%)
Phase 4Post-market surveillance
7(20.0%)
N/ANon-phased studies
20(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

22 of 24 finished

Non-Completion Rate

8.3%

2 ended early

Currently Active

8

trials recruiting

Total Trials

37

all time

Status Distribution
Active(10)
Completed(22)
Terminated(2)
Other(3)

Detailed Status

Completed22
Recruiting5
Active, not recruiting3
unknown3
Not yet recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
37
Active
8
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.9%)
Phase 11 (2.9%)
Phase 23 (8.6%)
Phase 33 (8.6%)
Phase 47 (20.0%)
N/A20 (57.1%)

Trials by Status

not_yet_recruiting25%
active_not_recruiting38%
unknown38%
completed2259%
recruiting514%
terminated25%

Recent Activity

Clinical Trials (37)

Showing 20 of 37 trialsScroll for more
NCT07593508Not Applicable

Diode Laser-Assisted Direct Pulp Capping Trial

Completed
NCT05084742

Long-term Performance and Safety of Biodentine™ in Patients Treated for Endodontic Indications

Active Not Recruiting
NCT07522723Not Applicable

Clinical and Radiographic Assessment of Bio C Repair, Biodentine and Mineral Trioxide Aggregate

Not Yet Recruiting
NCT06683833Phase 4

Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth

Recruiting
NCT04863222Phase 4

Clinical and Radiographic Success of MTA vs Biodentine

Recruiting
NCT07130214

The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy

Active Not Recruiting
NCT07120321Not Applicable

Pulpotomy Materials in Primary Molars

Completed
NCT05937100Not Applicable

New Vital Pulpotomy Medications in Primary Molars

Active Not Recruiting
NCT06695208Phase 4

Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth

Recruiting
NCT06468085Not Applicable

Evaluation of Pulpotomy Using Two Different Agents in Mature Anterior Teeth With Pulpitis

Not Yet Recruiting
NCT02492841Phase 2

Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth

Completed
NCT06435065Phase 4

Direct Pulp Capping Agent on Human Pulp Tissue

Recruiting
NCT06020911Phase 4

Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars

Completed
NCT04902495Not Applicable

Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

Recruiting
NCT04018456Not Applicable

Regenerative Endodontic Treatment of Mature Necrotic Teeth With Apical Periodontitis

Completed
NCT05719987Not Applicable

Biodentine as an Apical Plug in Immature Permanent Molars

Completed
NCT05582317Not Applicable

Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars

Completed
NCT02868918Phase 3

Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions

Completed
NCT05347160Not Applicable

Evaluation Of Different Pulpotomy Agents Used For Treatment Of Immature Molars

Unknown
NCT05006755Not Applicable

Comparison of Sealing Ability of MTA and Biodentine for Repairing of Furcal Perforation in Primary Molars

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
37